Drug Trial Radar · NCT00000655
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Last checked: Nov 20, 2026Latest source record: Mar 1, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Not stated
Primary completion
Jan 1992
Sponsor
- Sponsor type
- NIH
- Collaborators
- Glaxo Wellcome
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 2
- Model
- Parallel
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the effectiveness of atovaquone (566C80) compared to a standard antipneumocystis agent, (SMX/TMP), for the treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in AIDS patients. To compare the safety of short-term (21 days) treatment with 566C80 and SMX/TMP in AIDS patients with an acute episode of PCP. Standard therapies for acute treatment of PCP involve either SMX/TMP or pentamidine isetionate. Although both treatments are equally effective, side effects prevent completion of therapy in 11-55 percent of patients.
Conditions
- Pneumonia, Pneumocystis Carinii
- HIV Infections
Interventions
AtovaquoneDrug
Sulfamethoxazole-TrimethoprimDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
38 sites in 8 countries. Site status is shown where the registry gives one.
Univ of Alabama at Birmingham
Birmingham, Alabama
Kaiser Foundation Hosp
Harbor City, California
USC
Los Angeles, California
Dr Richard Meyer
Los Angeles, California
UCLA CARE Ctr
Los Angeles, California
Infectious Disease Med Group
Oakland, California
Univ of California / San Diego Treatment Ctr
San Diego, California
San Francisco Gen Hosp
San Francisco, California
UCSF - San Francisco Gen Hosp
San Francisco, California
Dr Marcus Conant
San Francisco, California
Georgetown Univ Med Ctr
Washington D.C., District of Columbia
Veterans Administration Med Ctr
Washington D.C., District of Columbia
Dr Winkler Weinberg
Roswell, Georgia
Johns Hopkins Univ School of Medicine
Baltimore, Maryland
Natl Inst of Allergy & Infect Dis / Cln Ctr
Bethesda, Maryland
Washington Univ School of Medicine
St Louis, Missouri
Beth Israel Med Ctr / Peter Krueger Clinic
New York, New York
Saint Vincent's Hosp and Med Ctr
New York, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr
New York, New York
Duke Univ Med Ctr
Durham, North Carolina
Univ of Cincinnati
Cincinnati, Ohio
Good Samaritan Hosp
Portland, Oregon
Buckley Braffman Stern Med Associates
Philadelphia, Pennsylvania
Regional Med Ctr at Memphis
Memphis, Tennessee
The Regional Medical Ctr, Memphis
Memphis, Tennessee
Plaza Med Ctr
Houston, Texas
Baylor College of Medicine
Houston, Texas
CHU Saint Pierre
Brussels, Belgium
Dr Julio S G Montaner
Vancouver, British Columbia, Canada
Wellesley Hosp
Toronto, Ontario, Canada
Montreal Gen Hosp
Montreal, Quebec, Canada
Hopital Bichat - Claude Bernard
Paris, France
August-Viktoria-Krankenhaus Chefarst derII Inneren Abteilung
Berlin, Germany
Universitat Munchen / Medizinische Poliklinik
Munich, Germany
Natac Med Centre
Amsterdam, Netherlands
San Juan Veterans Administration Med Ctr
San Juan, Puerto Rico
Kobler Centre / Saint Stephen's Hosp
London, United Kingdom
Saint Mary's Hosp
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.